Elevated expression of ZNF217 promotes prostate cancer growth by restraining ferroportin-conducted iron egress

Although we and other studies indicated ZNF217 expression was increased in prostate cancer (PCa), the factors mediating its misregulated expression and their oncogenic activity remain largely unexplored. Recent evidence demonstrated that ferroportin (FPN) reduction lead to decreased iron export and...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Xingkang, Zhang, Changwen, Qi, Shiyong, Guo, Shanqi, Chen, Yue, Du, E, Zhang, Hongtuan, Wang, Xiaoming, Liu, Ranlu, Qiao, Baomin, Yang, Kuo, Zhang, Zhihong, Xu, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356707/
https://www.ncbi.nlm.nih.gov/pubmed/27768596
http://dx.doi.org/10.18632/oncotarget.12753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356707/
https://www.ncbi.nlm.nih.gov/pubmed/27768596
http://dx.doi.org/10.18632/oncotarget.12753

Ejemplares similares